Article

Extracellular vesicles miR-574-5p and miR-181a-5p as prognostic markers in NSCLC patients treated with Nivolumab

2024-04-22

Abstract excerpt

<title>Abstract</title> <p>Background Immune checkpoint inhibitors (ICIs) have revolutionized the management of advanced non-small cell lung cancer (NSCLC), although patient survival is still unsatisfactory. Accurate predictive markers capable of personalizing the treatment of patients with NSCLC are still lacking. Circulating extracellular vesicles involved in cell-to-cell communications through miRNAs (EV-miRs...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 07e7e15e-2d7c-516c-a806-3c54daba7cbb
DOI: 10.21203/rs.3.rs-4258337/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Extracellular vesicles miR-574-5p and miR-181a-5p as prognostic markers in NSCLC patients treated with NivolumabDOI 10.21203/rs.3.rs-4258337/v1Read

Extracellular vesicles proteomics-based machine-learning model predicts immunotherapy response in NSCLCSemantic proximity Read

Combining Plasma Extracellular Vesicle Let-7b-5p, miR-184 and Circulating miR-22-3p Levels for NSCLC Diagnosis and for Predicting Drug ResistanceSemantic proximity Read

Extracellular Vesicle-Associated miRNAs as a Biomarker for Lung Cancer in Liquid BiopsySemantic proximity Read

Unveiling mutational dynamics in non-small cell lung cancer patients by quantitative EGFR profiling in vesicular RNA.Semantic proximity Read

Combining plasma extracellular vesicle Let-7b-5p, miR-184 and circulating miR-22-3p levels for NSCLC diagnosis and drug resistance prediction.Semantic proximity Read

Serum extracellular vesicle-derived microRNAs as potential biomarkers for pleural mesothelioma in a European prospective studySemantic proximity Read

Exosomal lncRNAs and cancer: connecting the missing linksSemantic proximity Read

Extra-cellular vesicles carry proteome of cancer hallmarksSemantic proximity Read

Exome Analysis Reveals Genomic Markers Associated with Better Efficacy of Nivolumab in Lung Cancer Patients.Semantic proximity Read

Tumor immune microenvironment and nivolumab efficacy in EGFR mutation-positive non-small-cell lung cancer based on T790M status after disease progression during EGFR-TKI treatment.Semantic proximity Read

A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC.Semantic proximity Read

Nivolumab after cyclophosphamide and doxorubicin induction chemotherapy in previously treated patients with EGFR or ALK wild type non-squamous cell non-small cell lung cancer with less than 10% of PD-L1 expressionSemantic proximity Read